Cargando…
Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice
Autores principales: | Guan, Lili, Zhou, Luqian, Le Grange, Jehane Michael, Zheng, Zeguang, Chen, Rongchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289232/ https://www.ncbi.nlm.nih.gov/pubmed/32527302 http://dx.doi.org/10.1186/s13054-020-03054-7 |
Ejemplares similares
-
Improved mechanical ventilation requires more than just increased ventilator availability: A word of caution
por: Guan, Lili, et al.
Publicado: (2020) -
Helmet CPAP versus Oxygen Therapy in Hypoxemic Acute Respiratory Failure: A Meta-Analysis of Randomized Controlled Trials
por: Luo, Yuwen, et al.
Publicado: (2016) -
Noninvasive Ventilation in Patients With COVID-19-Related Acute Hypoxemic Respiratory Failure: A Retrospective Cohort Study
por: Fu, Yingyun, et al.
Publicado: (2021) -
COVID-19: Non-Invasive Ventilation in Hypoxemic Acute Respiratory Failure
por: Rezaeitalab, Fariborz, et al.
Publicado: (2022) -
ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19
por: Colaianni-Alfonso, Nicolás, et al.
Publicado: (2022)